Australia's Vaxxas advances $4.8 M programme for needle-free thermostable mRNA vaccines
Vaccines | News | 0 Comment | 23 Jan, 2025
Vaxxas, an Australia-based clinical-stage biotechnology company commercialising a novel high-density microarray patch (H...Read more
Harnessing mRNA technology to tackle unmet medical needs in Asia
Vaccines | Opinion | 0 Comment | 21 Jan, 2025
Asia is emerging as a hub for biopharmaceuticals and vaccine manufacturing, leveraging its strengths in manufacturing an...Read more
UQ and Vaxxas in Australia win $2 M from US to advance patch-based mRNA COVID-19 vaccine
Vaccines | News | 0 Comment | 14 Jan, 2025
Australia-based University of Queensland’s (UQ) BASE facility, within the Australian Institute for Bioenginee...Read more
TechInvention partners with Ethiopia's Ministry of Health to advance vaccine manufacturing in Africa
Vaccines | News | 0 Comment | 06 Jan, 2025
In a significant step toward enhancing vaccine self-sufficiency and pandemic preparedness in Africa, TechInvention, an I...Read more
SK bioscience inks KRW 75.5 B deal with Sanofi to develop next-gen pneumococcal conjugate vaccines
Vaccines | News | 0 Comment | 23 Dec, 2024
South Korea-based SK bioscience and French pharmaceutical firm Sanofi have announced the signing of an expanded agreem...Read more
Building vaccine and therapeutics manufacturing capacity in Asia Pacific
Vaccines | News | 0 Comment | 20 Dec, 2024
Scientists from Australia's Biomedical Manufacturing Programme are partnering with Thailand and Malaysia to en...Read more
Consortium set to further establish vaccine safety evidence-generation network in Africa
Vaccines | News | 0 Comment | 17 Dec, 2024
A research consortium is set to further establish a vaccine safety evidence-generation network in Africa, seeking to und...Read more
Vaccines | News | 0 Comment | 13 Dec, 2024
South Korea-based SK bioscience, a global innovative vaccine and biotech company, has received approval from the Human R...Read more
Moderna officially opens new vaccine manufacturing facility in Australia
Vaccines | News | 0 Comment | 10 Dec, 2024
Moderna has officially launched its new vaccine manufacturing facility at Monash University’s Clayton campus in so...Read more
Hong Kong approves Pfizer's 20-valent Pneumococcal Conjugate Vaccine for infants and children
Vaccines | News | 0 Comment | 03 Dec, 2024
American pharmaceutical firm Pfizer has announced that the Hong Kong Department of Health (DoH) has approved the company...Read more
Sanofi introduces 'Modulus', world’s first modular manufacturing facility in Singapore
Vaccines | News | 0 Comment | 27 Nov, 2024
Sanofi announced the inauguration of its state-of-theart manufacturing facility, Modulus, in Singapore, on 27 Nov, marki...Read more
Korea-Africa partnership for advancing vaccine end-to-end capabilities
Vaccines | News | 0 Comment | 27 Nov, 2024
The Government of the Republic of Kenya and the International Vaccine Institute (IVI) in South Korea, have signed a Memo...Read more
Sanofi, A*STAR and NSC collaborate to advance Acne Vaccine R&D in Singapore
Vaccines | News | 0 Comment | 22 Nov, 2024
Sanofi, the Agency for Science, Technology and Research (A*STAR), and the National Skin Centre Singapore (NSC) establish...Read more
Vaccines | Analysis | By Ankit Kankar | ankit.kankar@mmactiv.com | 0 Comment | 25 Nov, 2024
Vaccines are the bedrock of public health, providing preventive solutions against infectious diseases while increasingly...Read more
Meiji Seika Pharma invests in ARCALIS to boost production of mRNA vaccines in Japan
Vaccines | News | 0 Comment | 18 Nov, 2024
Japan-based Meiji Seika Pharma Co. has announced its investment in ARCALIS, Inc. which is a joint venture between Axcele...Read more
Australia's Vaxxas licenses next-gen vaccine for Respiratory Syncytial Virus from NIH
Vaccines | News | 2 Comment | 29 Oct, 2024
Australia-based Vaxxas, a clinical-stage biotechnology company commercialising a novel high-density microarray patc...Read more
SK bioscience's Quadrivalent Influenza Vaccine SKYCellflu approved in Indonesia
Vaccines | News | 0 Comment | 23 Oct, 2024
SK bioscience, a global innovator in vaccines and biotechnology, announced that Indonesia's Food and Drug Agency, BPOM (...Read more
CEPI supports advancement of open-access coronavirus vaccines R&D roadmap with $3.2 M funding
Vaccines | News | 0 Comment | 13 Oct, 2024
The Center for Infectious Disease Research and Policy (CIDRAP) at the University of Minnesota, US will receive $3.2 mill...Read more